Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Stull DM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ailawadhi S; Mayo Clinic, Jacksonville, FL 32224, USA., Cheng M; Analysis Group, Inc., Boston, MA 02199, USA. Electronic address: Mu.Cheng@analysisgroup.com., Cherepanov D; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA., DerSarkissian M; Analysis Group, Inc., Boston, MA 02199, USA., Stull DM; Takeda Development Center Americas, Inc., Lexington, MA 02421, USA., Hilts A; Analysis Group, Inc., Boston, MA 02199, USA., Chun J; Analysis Group, Inc., Boston, MA 02199, USA., Duh MS; Analysis Group, Inc., Boston, MA 02199, USA., Sanchez L; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Publikováno v:
Current problems in cancer [Curr Probl Cancer] 2024 Jun; Vol. 50, pp. 101078. Date of Electronic Publication: 2024 Mar 27.
Autor:
Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, 86000, France., Lee HC; M.D. Anderson Cancer Center, Houston, TX 77030, USA., Zonder JA; Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI 48201, USA., Macro M; CHU de Caen, Caen, 14000, France., Ramasamy K; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, Oxfordshire, OX3 7LE, UK., Hulin C; CHU de Bordeaux, Bordeaux, 33000, France., Silar J; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Kuhn M; Institute of Biostatistics & Analyses, Ltd, Brno, 602 00, Czech Republic., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA., Bent-Ennakhil N; Takeda Pharmaceuticals International AG, Opfikon, 8152, Switzerland., Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02421, USA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Terpos E; Department of Clinical Therapeutics, National & Kapodistrian University of Athens, School of Medicine, Athens,115 27, Greece.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 May; Vol. 20 (14), pp. 935-950. Date of Electronic Publication: 2024 Jan 10.
Autor:
Ludwig H; First Department of Medicine, Wilhelminen Cancer Research Institute, Center for Oncology and Hematology, Clinic Ottakring, Vienna, Austria. Electronic address: heinz.ludwig@extern.gesundheitsverbund.at., Ramasamy K; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Mateos MV; Department of Hematology, University Hospital of Salamanca, IBSAL, CIC, IBMCC (USAL-CSIC), Salamanca, Spain., Kishore B; Heart of England/University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom., Gergely V; Faculty of Medicine Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary., Ladicka M; National Cancer Institute, Bratislava, Slovakia., Ori A; MediNeos, Observational Research, Modena, Italy., Simoni L; MediNeos, Observational Research, Modena, Italy., Bent-Ennakhil N; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Gavini F; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Hájek R; Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic; Department of Haematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. e40-e49.e3. Date of Electronic Publication: 2023 Oct 14.
Autor:
Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO 80218, USA., Costello CL; Department of Medicine, Division of Blood & Marrow Transplantation, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA., Birhiray RE; Hematology Oncology of Indiana/American Oncology Network, Indianapolis, IN 46260, USA., Kambhampati S; Kansas City Veterans Affairs Medical Center, Kansas City, MO 64128, USA., Richter J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Abonour R; Indiana University School of Medicine, Indianapolis, IN 46202, USA., Lee HC; M.D. Anderson Cancer Center, Houston, TX 77030, USA., Stokes M; Evidera, Data Analytics, St-Laurent, Quebec, H4T 1V6, Canada., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02412, USA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Cherepanov D; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA 02412, USA., Bogard K; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Noga SJ; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA 02421, USA., Girnius S; TriHealth Cancer Institute, Cincinnati, OH 45247, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Jan; Vol. 20 (3), pp. 131-143. Date of Electronic Publication: 2023 Oct 09.
Autor:
Sanchez L; Icahn School of Medicine at Mount Sinai, New York, NY., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY., Cheng M; Analysis Group, Inc., Boston, MA., Cherepanov D; Takeda Development Center Americas, Lexington, MA., DerSarkissian M; Analysis Group, Inc., Boston, MA., Huang F; Takeda Development Center Americas, Lexington, MA., Stull DM; Takeda Development Center Americas, Lexington, MA., Dabora J; Takeda Development Center Americas, Lexington, MA., Young M; Takeda Development Center Americas, Lexington, MA., Noga SJ; Takeda Development Center Americas, Lexington, MA., Pi S; Analysis Group, Inc., Boston, MA., Zhang M; Analysis Group, Inc., Boston, MA., Banatwala A; Analysis Group, Inc., Boston, MA., Duh MS; Analysis Group, Inc., Boston, MA., Ailawadhi S; Mayo Clinic, Jacksonville, FL.
Publikováno v:
Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2023 Nov; Vol. 29 (11), pp. 1205-1218. Date of Electronic Publication: 2023 Sep 30.
Autor:
Thompson MA; Aurora Cancer Care, Advocate Aurora Research Institute, Advocate Aurora Health, Milwaukee, WI,. Electronic address: michael.thompson@tempus.com., Boccadoro M; Division of Hematology, University of Torino, Torino, Italy., Leleu X; Pôle Régional de Cancérologie, Department of Hematology, CHU La Milétrie-Poitiers, Poitiers, France., Vela-Ojeda J; Department of Hematology, UMAE Hospital de Especialidades Centro Medico La Raza IMSS, Mexico City, Mexico., van Rhee F; University of Arkansas for Medical Sciences, Little Rock, AR., Weisel KC; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Rifkin RM; Rocky Mountain Cancer Centers/US Oncology Research, Denver, CO., Usmani SZ; Levine Cancer Institute, Charlotte, NC., Hájek R; Department of Hemato-oncology, University Hospital Ostrava, and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic., Cook G; Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, UK., Abonour R; Indiana University School of Medicine, Indianapolis, IN., Armour M; Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia., Morgan KE; Myeloma Patients Europe, Brussels, Belgium., Yeh SP; China Medical University Hospital, Taichung City, P.R.China., Costello CL; University of California San Diego, La Jolla, CA., Berdeja JG; Department of Hematology, Tennessee Oncology and Sarah Cannon Research Institute, Nashville, TN., Davies FE; Perlmutter Cancer Center, NYU Langone, New York, NY., Zonder JA; Department of Malignant Hematology, Barbara Ann Karmanos Cancer Institute/Wayne State University School of Medicine, Detroit, MI., Lee HC; Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX., Omel J; The Central Nebraska Myeloma Support Group, Grand Island, NE., Spencer A; Malignant Haematology and Stem Cell Transplantation Service, Alfred Health Monash University, Melbourne, Australia., Terpos E; Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece., Hungria VTM; Department of Hematology, Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil., Puig N; Hematology Department, Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain., Fu C; First Affiliated Hospital, Soochow University, Suzhou Jiangsu, P.R.China., Ferrari RH; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Ren K; Takeda Development Center Americas, Inc. (TDCA), Lexington, MA., Stull DM; Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA., Chari A; Department of Hematology-Oncology, Mount Sinai School of Medicine, New York, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Mar; Vol. 23 (3), pp. e171-e181. Date of Electronic Publication: 2022 Dec 07.
Autor:
Fogaren T; Tufts Medical Center., Shelton AC; Boston University., Faller DV; Takeda Development Center Americas, Inc., Stull DM; Takeda Pharmaceuticals., Thuenemann S; Takeda Pharmaceuticals., Mendelson L; Boston University.
Publikováno v:
Clinical journal of oncology nursing [Clin J Oncol Nurs] 2022 Jul 25; Vol. 26 (4), pp. 421-432.